BioSpace News Archive

Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the third quarter ended September 30, 2020 and provided an update on recent business progress. For the third quarter of 2020, revenue was $31.1 million, compared to $20.7 million in the second quarter of 2020 and $31.0 million in the third quarter of 2019.

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a first-in-class immuno-oncology product candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma), will host a conference call on November 9, 2020 at 4:30 p.m. ET to report its financial results for the third quarter ended September 30, 2020 and provide an update on the company.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the 29th Annual Credit Suisse Virtual Healthcare Conference on Monday, November 9, 2020 at 3:30 p.m. E.T.

ImmunoGen, Inc. announced that on October 30, 2020 the compensation committee of the Company’s Board of Directors granted a non-qualified stock option award to purchase an aggregate of 21,500 shares of its common stock to a new employee under the ImmunoGen, Inc.

3D-printed anatomical models replicate biomechanics of human anatomy to help improve training, transform surgical planning and bring new medical innovations to market faster

Co-Diagnostics, Inc. announced that following the discovery of an incorrectly recorded expense in the period ending June 30, 2020, Management will be amending its June 30, 2020 Form 10-Q by filing Amendment No. 1 on Form 10-Q/A with the Securities and Exchange Commission to show an increase in basic and diluted net income per common share of $0.08 as of and for the three and six months ended June 30, 2020.

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, announced that third quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, November 12th.

Align Technology, Inc. announced the opening of its 2021 Research Award Program to support clinical and scientific dental research in universities across the globe.

Perrigo Company plc, a leading global provider of Quality, Affordable Self-Care Products, announced that it has completed the acquisition of three Eastern European OTC skincare and hair loss treatment brands, Emolium®, Iwostin® and Loxon® from Sanofi.

Syneos Health®, the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO, announced that management is scheduled to present at two upcoming investor conferences